In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Humana Inc (NYSE: HUM) closed at $256.04 down -2.36% from its previous closing price of $262.24. In other words, the price has decreased by -$2.36 from its previous closing price. On the day, 1.75 million shares were traded. HUM stock price reached its highest trading level at $266.83 during the session, while it also had its lowest trading level at $255.69.
Ratios:
For a deeper understanding of Humana Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.70.
On November 06, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $247 to $308.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 08 ’25 when Diamond Susan M bought 10,959 shares for $249.31 per share.
Huval Timothy S. bought 1,247 shares of HUM for $322,443 on Feb 24 ’25. On Dec 31 ’24, another insider, Huval Timothy S., who serves as the Chief Administrative Officer of the company, sold 3,703 shares for $256.26 each. As a result, the insider received 948,925 and left with 8,181 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 30902237184 and an Enterprise Value of 22508357632. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.71, and their Forward P/E ratio for the next fiscal year is 17.69. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 1.89. Its current Enterprise Value per Revenue stands at 0.187 whereas that against EBITDA is 5.494.
Stock Price History:
The Beta on a monthly basis for HUM is 0.50, which has changed by -0.20122296 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $406.46, while it has fallen to a 52-week low of $213.31. The 50-Day Moving Average of the stock is -3.50%, while the 200-Day Moving Average is calculated to be -12.23%.
Shares Statistics:
For the past three months, HUM has traded an average of 1.73M shares per day and 1974520 over the past ten days. A total of 120.64M shares are outstanding, with a floating share count of 120.43M. Insiders hold about 0.22% of the company’s shares, while institutions hold 97.21% stake in the company. Shares short for HUM as of 1744675200 were 3123714 with a Short Ratio of 1.81, compared to 1741910400 on 3332285. Therefore, it implies a Short% of Shares Outstanding of 3123714 and a Short% of Float of 2.9000001.
Dividends & Splits
According to the company, the forward annual dividend rate for HUM is 3.54, from 3.54 in the trailing year. Against a Trailing Annual Dividend Yield of 0.013499085The stock’s 5-year Average Dividend Yield is 0.77. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-03-28 with an ex-dividend date of 1750982400. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
The market rating for Humana Inc (HUM) is a result of the insights provided by 22.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $2.77, with high estimates of $3.82 and low estimates of $1.58.
Analysts are recommending an EPS of between $16.98 and $15.93 for the fiscal current year, implying an average EPS of $16.35. EPS for the following year is $14.25, with 23.0 analysts recommending between $16.54 and $10.55.
Revenue Estimates
A total of 14 analysts believe the company’s revenue will be $31.62B this quarter.It ranges from a high estimate of $32.19B to a low estimate of $30.62B. As of the current estimate, Humana Inc’s year-ago sales were $29.54BFor the next quarter, 14 analysts are estimating revenue of $31.27B. There is a high estimate of $31.9B for the next quarter, whereas the lowest estimate is $30.36B.
A total of 19 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $127.44B, while the lowest revenue estimate was $122.38B, resulting in an average revenue estimate of $126.16B. In the same quarter a year ago, actual revenue was $117.76BBased on 19 analysts’ estimates, the company’s revenue will be $129.7B in the next fiscal year. The high estimate is $139.35B and the low estimate is $120.94B.
